Medication
Back to all medications
Neurological

Levetiracetam (Keppra) in Dogs & Cats

Generic: Levetiracetam

Levetiracetam is a versatile anticonvulsant medication used to manage seizures in dogs and cats, often employed as an add-on therapy or in cases where traditional maintenance medications are insufficient.

This medication is intended for dogs and cats.

RxDogs & Cats

Overview

Levetiracetam, commercially known as Keppra, is an effective antiepileptic drug that belongs to the pyrrolidine class of chemicals. Unlike older seizure medications such as Phenobarbital or Potassium Bromide, levetiracetam offers a unique pharmacokinetic profile characterized by a shorter half-life and less reliance on hepatic metabolism. It is frequently utilized in veterinary medicine to stabilize patients experiencing cluster seizures or those who have developed resistance to primary treatments. Veterinarians may also consider it alongside Zonisamide or Gabapentin (Neuro) to achieve better seizure control with fewer systemic side effects.

In clinical practice, the medication is prized for its high safety margin and minimal drug-drug interaction profile compared to traditional agents. Because it is excreted primarily through the kidneys, it is a favorable option for patients with impaired liver function who cannot tolerate medications like Felbamate. While oral administration is the standard for long-term seizure management, the injectable formulation can be used during acute seizure crises, often alongside emergency interventions like Diazepam (Neuro) to halt status epilepticus.

Beyond basic maintenance, levetiracetam is increasingly used as a pulse therapy or in specific neurological conditions where rapid onset of action is required. When Imepitoin or other maintenance therapies provide inadequate control, levetiracetam is often the first-line 'add-on' choice. Its rapid absorption ensures that therapeutic levels are reached quickly, providing a reliable buffer for pets struggling with idiopathic epilepsy or structural seizure disorders. Despite its efficacy, owners must be strictly compliant with the dosing schedule, as the shorter half-life requires consistent intervals to prevent 'breakthrough' seizure activity.

What It Treats

  • Idiopathic Epilepsy: Chronic recurring seizures with no identifiable underlying cause.
  • Structural Seizure Disorders: Seizures caused by brain lesions, tumors, or inflammation.
  • Status Epilepticus: Used in injectable form to help arrest prolonged, life-threatening seizure activity.
  • Cluster Seizures: High-frequency seizure events that require rapid therapeutic intervention.

How It Works

Levetiracetam works through a novel mechanism compared to traditional anticonvulsants. It selectively binds to the synaptic vesicle protein SV2A, which is involved in the release of neurotransmitters. By modulating this protein, levetiracetam inhibits the excessive firing of excitatory neurons in the brain without affecting normal neurotransmission significantly. This specific action allows it to suppress seizure activity while causing less sedation or cognitive impairment than traditional barbiturates. Furthermore, it modulates neurotransmitter release, effectively dampening the hypersynchronous electrical storms that manifest as physical seizures in affected pets.

Dosage

Dosage is highly variable depending on the patient's condition and whether the drug is used as a monotherapy or an add-on. Common doses for dogs range from 20mg/kg to 60mg/kg administered every 8 hours. Cats generally require similar dosing frequencies, though specific body surface area calculations may apply. It is critical to adhere strictly to the schedule prescribed by your veterinarian; missing a dose can cause a drop in serum levels, potentially triggering a breakthrough seizure.

Administration

Levetiracetam is typically administered orally as a tablet or liquid suspension. The standard frequency is three times daily (every 8 hours) due to its rapid clearance from the body. It can be given with or without food, though food may help reduce any potential stomach upset. Always ensure that the exact dose is measured using a veterinary-provided syringe if using a liquid formulation, as human formulations may contain xylitol, which is toxic to dogs.

Storage

Store levetiracetam at controlled room temperature, typically between 68°F and 77°F (20°C to 25°C). The medication should be kept in a tightly closed container away from direct sunlight, heat, and moisture. Keep all medications out of the reach of children and pets, and do not store in the bathroom or kitchen where humidity levels fluctuate.

Contraindications

Levetiracetam should be used with extreme caution in patients with significant renal impairment, as the drug is primarily eliminated through the kidneys. Dosage adjustments or increased monitoring are necessary for these patients to prevent toxicity. It is also contraindicated in pets with a known hypersensitivity to the drug or other pyrrolidine derivatives. Furthermore, caution is advised for pregnant or nursing animals, as the safety profile for developing fetuses has not been fully established. While it is generally considered safer than many alternatives, the decision to use it during pregnancy should only be made by a veterinarian who has conducted a thorough risk-benefit analysis based on the severity of the mother's seizure disorder.

Interactions

Levetiracetam has a relatively low interaction profile compared to other anticonvulsants, making it safer to combine with other medications. However, additive sedative effects may occur if it is administered concurrently with other CNS-depressant drugs or sedatives. Because levetiracetam is not highly protein-bound, it does not typically displace other drugs from binding sites in the blood, which reduces the complexity of drug-drug interactions. Nevertheless, caution is always warranted when adding this medication to an existing regimen that includes other liver-metabolized drugs or seizure control medications. Always inform your veterinarian of all supplements, herbal remedies, and prescriptions the patient is currently receiving to ensure that therapeutic drug monitoring can be adjusted appropriately.

Side Effects

  • Lethargy or drowsiness
  • Ataxia (uncoordinated movement or staggering)
  • Behavioral changes (irritability or restlessness)
  • Decreased appetite
  • Vomiting
  • Hypersalivation (especially in cats)
  • Rare cases of severe allergic reaction (hives or facial swelling)

Frequently Asked Questions

This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.

Find a Pharmacy

Related Medications

Gabapentin (Neuro)

Gabapentin is a versatile prescription medication primarily utilized in veterinary medicine to manage chronic pain and neurological conditions such as seizures and anxiety in both dogs and cats.

Brivaracetam

Brivaracetam is a novel anti-epileptic drug used primarily in dogs and cats as an adjunctive therapy for the management of refractory seizures.

Prednisolone (Neuro)

Prednisolone is a potent synthetic glucocorticoid used in veterinary medicine to reduce inflammation and suppress the immune system, particularly in the management of complex neurological disorders.

Clonazepam (Neuro)

Clonazepam is a benzodiazepine medication primarily utilized in veterinary medicine as an adjunct therapy for the management of refractory seizure disorders and anxiety-related behavioral conditions in dogs and cats.

Rufinamide

Rufinamide is an add-on prescription anticonvulsant medication used in veterinary medicine primarily to assist in managing refractory epilepsy in dogs and cats when other first-line therapies have failed to provide adequate seizure control.

Clorazepate

Clorazepate is a benzodiazepine medication used in veterinary medicine primarily as an adjunctive anticonvulsant and anxiolytic agent for dogs and cats.

Topiramate

Topiramate is a prescription anticonvulsant medication used as an adjunctive therapy in dogs and cats to manage refractory seizures.

Zonisamide

Zonisamide is a sulfonamide anticonvulsant used primarily as an adjunctive therapy for the management of refractory epilepsy in dogs and occasionally in cats.